Literature DB >> 32278258

Semantic characterization of adverse outcome pathways.

Rong-Lin Wang1.   

Abstract

This study was undertaken to systematically assess the utilities and performance of ontology-based semantic analysis in adverse outcome pathway (AOP) research. With an increasing number of AOPs developed by scientific domain experts to organize toxicity information and facilitate chemical risk assessment, there is a pressing need for objective approaches to evaluate the biological coherence and quality of these AOPs. Powered by ontologies covering a wide range of biological domains, abundant phenotypic data annotated ontologically, and some sophisticated knowledge computing tools, semantic analysis has great potential in this area of application. With the events in the AOP-Wiki first annotated into logical definitions and then grouped into phenotypic profiles by individual AOPs, the coherence and quality of AOPs were assessed at several levels: paired key event relationships (KER), all possible event pair combinations within AOPs, and the phenotypic profiles of AOPs, genes, biological pathways, human diseases, and selected chemicals. The semantic similarities were assessed at all these levels based on a unified cross-species vertebrate phenotype ontology encompassing the logical definitions of AOP events as well as many other domain ontologies. A substantial number of KERs and AOPs in the AOP-Wiki were found to be semantically coherent. These same coherent AOPs also mapped to many more genes, pathways, and diseases biologically aligned with the intended chain of events therein leading to their respective adverse outcomes. Significantly, these findings imply that semantic analysis should also have utilities in developing future AOPs by selecting candidate events from either the existing AOP-Wiki events or a broader collection of ontology terms semantically similar to the molecular initiating events or adverse outcomes of interest. In addition, semantic analysis enabled AOP networks to be constructed at the level of phenotypic profiles based on similarities, complementing those based on event sharing by bringing genes, pathways, diseases, and chemicals into the networks too-thus greatly expanding the biological scope and our understanding of AOPs. Published by Elsevier B.V.

Entities:  

Keywords:  Adverse outcome pathway; Ontology; Semantic analysis; Toxicity event network

Mesh:

Year:  2020        PMID: 32278258      PMCID: PMC7393770          DOI: 10.1016/j.aquatox.2020.105478

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  24 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

Review 2.  piRNAs and their involvement in male germline development in mice.

Authors:  Ramesh S Pillai; Shinichiro Chuma
Journal:  Dev Growth Differ       Date:  2012-01-06       Impact factor: 2.053

Review 3.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

Review 4.  High-throughput mouse phenomics for characterizing mammalian gene function.

Authors:  Steve D M Brown; Chris C Holmes; Ann-Marie Mallon; Terrence F Meehan; Damian Smedley; Sara Wells
Journal:  Nat Rev Genet       Date:  2018-06       Impact factor: 53.242

5.  Adverse outcome pathway development II: best practices.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

6.  Adverse outcome pathway (AOP) development I: strategies and principles.

Authors:  Daniel L Villeneuve; Doug Crump; Natàlia Garcia-Reyero; Markus Hecker; Thomas H Hutchinson; Carlie A LaLone; Brigitte Landesmann; Teresa Lettieri; Sharon Munn; Malgorzata Nepelska; Mary Ann Ottinger; Lucia Vergauwen; Maurice Whelan
Journal:  Toxicol Sci       Date:  2014-12       Impact factor: 4.849

7.  Cross-product extensions of the Gene Ontology.

Authors:  Christopher J Mungall; Michael Bada; Tanya Z Berardini; Jennifer Deegan; Amelia Ireland; Midori A Harris; David P Hill; Jane Lomax
Journal:  J Biomed Inform       Date:  2010-02-10       Impact factor: 6.317

8.  Linking human diseases to animal models using ontology-based phenotype annotation.

Authors:  Nicole L Washington; Melissa A Haendel; Christopher J Mungall; Michael Ashburner; Monte Westerfield; Suzanna E Lewis
Journal:  PLoS Biol       Date:  2009-11-24       Impact factor: 8.029

Review 9.  Polyunsaturated fatty acids in male and female reproduction.

Authors:  D Claire Wathes; D Robert E Abayasekara; R John Aitken
Journal:  Biol Reprod       Date:  2007-04-18       Impact factor: 4.285

10.  A survey of ontology learning techniques and applications.

Authors:  Muhammad Nabeel Asim; Muhammad Wasim; Muhammad Usman Ghani Khan; Waqar Mahmood; Hafiza Mahnoor Abbasi
Journal:  Database (Oxford)       Date:  2018-01-01       Impact factor: 3.451

View more
  3 in total

1.  Knowledge Organization Systems for Systematic Chemical Assessments.

Authors:  Paul Whaley; Stephen W Edwards; Andrew Kraft; Kate Nyhan; Andrew Shapiro; Sean Watford; Steve Wattam; Taylor Wolffe; Michelle Angrish
Journal:  Environ Health Perspect       Date:  2020-12-24       Impact factor: 9.031

Review 2.  Trends in the Application of "Omics" to Ecotoxicology and Stress Ecology.

Authors:  Joshua Niklas Ebner
Journal:  Genes (Basel)       Date:  2021-09-23       Impact factor: 4.096

3.  A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.

Authors:  Terje Svingen; Daniel L Villeneuve; Dries Knapen; Eleftheria Maria Panagiotou; Monica Kam Draskau; Pauliina Damdimopoulou; Jason M O'Brien
Journal:  Toxicol Sci       Date:  2021-11-24       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.